Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...
News headlines Energy Transfer LP (ET) is focusing on significant natural gas network expansions with a planned investment of $5-5.5 billion for 2026. However, the company has halted the Lake Charles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback